Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: Joe Wesley who wrote (1964)	5/5/1998 10:13:00 AM
From: sds	Read Replies (1) \| Respond to of 4676

AA, I don't think you are going to see that kind of move.... I hate to be overly skeptical, but I don't think its in the cards. First of all, just about everybody who matters has heard of Isis. Believe it or not, but they are rather well-known among b-tech analysts and portfolio managers. Also, none of their drugs has shown that amazing level of efficacy in mice. I think Isis could still end up being a huge winner, but I don't think you're ever going to see that one-day spike like ENMD did yesterday. Perhaps, if one their cancer drugs REALLY works well or the RA indication really seems to work well, you'd see a big pop... sds